PGR and breast carcinoma: In addition to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2/neu (HER2/neu), a number of additional markers have been thoroughly investigated to determine their association with the clinicopathological features of breast cancer as well as their function in treatment selection and outcome modification.